Seidelmann and colleagues [52] found that persons with alterations in the SLC5A1 gene—resulting in production of functionally damaged SGLT1—are at substantially lower risk of developing T2DM and HF (23% and 30% relative risk reductions, respectively). The gene discussed is SLC5A1; the disease is hydrops fetalis.